{"abstract": "Johnson & Johnson and GlaxoSmithKline are teaming up with the venture capital firm Index Ventures on a $199 million fund aimed at the life sciences sector.", "web_url": "https://dealbook.nytimes.com/2012/03/21/pharmaceutical-giants-back-new-venture-capital-fund/", "snippet": "Johnson & Johnson and GlaxoSmithKline are teaming up with the venture capital firm Index Ventures on a $199 million fund aimed at the life sciences sector.", "lead_paragraph": "Johnson & Johnson and GlaxoSmithKline, the pharmaceutical giants, are teaming up with the venture capital firm Index Ventures on a 150 million euro ($199 million) fund targeted at the life sciences sector. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Drug Giants Back New Venture Capital Fund", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Venture Capital", "rank": 2, "major": "N"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Skype Technologies", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Songkick.com", "rank": 6, "major": "N"}], "pub_date": "2012-03-21T13:06:26+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Mark Scott", "person": [{"firstname": "Mark", "middlename": null, "lastname": "Scott", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c2ae0038-e68e-545b-a4b2-13bb90e8d937", "word_count": 301, "uri": "nyt://article/c2ae0038-e68e-545b-a4b2-13bb90e8d937"}